Filtros de búsqueda

Lista de obras de Timothy Perren

30-day mortality after systemic anticancer treatment for breast and lung cancer in England: a population-based, observational study ⬇️

artículo científico publicado en 2016

A functional form for a representative individual arterial input function measured from a population using high temporal resolution DCE MRI

artículo científico publicado en 2018

A novel continuous infusional 5-fluorouracil-based chemotherapy regimen compared with conventional chemotherapy in the neo-adjuvant treatment of early breast cancer: 5 year results of the TOPIC trial

artículo científico publicado en 2004

A phase 3 trial of bevacizumab in ovarian cancer ⬇️

artículo científico publicado en 2011

A phase II feasibility study of carboplatin followed by sequential weekly paclitaxel and gemcitabine as first-line treatment for ovarian cancer ⬇️

artículo científico publicado en 2004

A phase II study of recombinant interferon-beta (r-hIFN-beta 1a) in combination with 5-fluorouracil (5-FU) in the treatment of patients with advanced colorectal carcinoma ⬇️

artículo científico publicado en 1997

A phase II trial evaluating two schedules of sagopilone (ZK-EPO), a novel epothilone, in patients with platinum-resistant ovarian cancer

artículo científico publicado en 2011

A prospective randomised phase II trial of thalidomide with carboplatin compared with carboplatin alone as a first-line therapy in women with ovarian cancer, with evaluation of potential surrogate markers of angiogenesis

artículo científico publicado en 2011

A randomised comparative trial of infusional ECisF versus conventional FEC as adjuvant chemotherapy in early breast cancer: the TRAFIC trial.

artículo científico publicado en 2010

A randomised study of carboplatin vs sequential ifosfamide/carboplatin for patients with FIGO stage III epithelial ovarian carcinoma. The London Gynaecologic Oncology Group. ⬇️

artículo científico publicado en 1993

Anthracycline-induced cardiomyopathy in siblings with early breast cancer

artículo científico publicado en 2011

Bevacizumab May Differentially Improve Ovarian Cancer Outcome in Patients with Proliferative and Mesenchymal Molecular Subtypes.

artículo científico publicado en 2017

Block sequential adriamycin CMF--optimal non-myeloablative chemotherapy for high risk adjuvant breast cancer? ⬇️

artículo científico publicado en 2002

CT appearances and prognostic significance of splenic metastasis in ovarian cancer.

artículo científico publicado en 1998

CT demonstration of calcified metastatic mediastinal lymph nodes

scientific article published on 01 December 1998

Carboplatin and ifosfamide in ovarian cancer phase II and III trials. London Gynaecological Oncology Group

artículo científico publicado en 1990

Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trial.

artículo científico publicado en 2016

Chemotherapy for malignant melanoma: combinations and high doses produce more responses without survival benefit ⬇️

artículo científico publicado en 1990

Chemotherapy for ovarian cancer--a consensus statement on standard practice. ⬇️

artículo científico publicado en 1998

Circulating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies. ⬇️

artículo científico publicado en 1993

Development of antiangiogenic agents for ovarian cancer.

scientific article published on January 2008

Discordance between the results and conclusions of ICON7 - Authors' reply.

artículo científico publicado en 2015

Dose-finding study of weekly docetaxel, epirubicin and capecitabine, as first-line treatment in advanced breast cancer.

artículo científico publicado en 2009

Effect of neoadjuvant chemotherapy on breast cancer phenotype, ER/PR and HER2 expression - Implications for the practising oncologist.

artículo científico publicado en 2016

Effects of interleukin 6 administration on platelets and haemopoietic progenitor cells in peripheral blood.

artículo científico publicado en 1996

Etoposide and adriamycin containing combination chemotherapy (HOPE-Bleo) for relapsed Hodgkin's disease ⬇️

artículo científico publicado el 1 de junio de 1990

Exploratory outcome analyses according to stage and/or residual disease in the ICON7 trial of carboplatin and paclitaxel with or without bevacizumab for newly diagnosed ovarian cancer ⬇️

artículo científico publicado en 2018

Feasibility and compliance of automated measurement of quality of life in oncology practice.

artículo científico publicado en 2003

Five-year outcome for women randomised in a phase III trial comparing doxorubicin and cyclophosphamide with doxorubicin and docetaxel as primary medical therapy in early breast cancer: an Anglo-Celtic Cooperative Oncology Group study.

artículo científico publicado en 2010

Glutathione reduces the toxicity and improves quality of life of women diagnosed with ovarian cancer treated with cisplatin: results of a double-blind, randomised trial.

artículo científico publicado en 1997

Good manners for the pharmaceutical industry

High EMSY expression defines a BRCA-like subgroup of high-grade serous ovarian carcinoma with prolonged survival and hypersensitivity to platinum

scientific article published on 02 June 2019

High dose BCNU chemotherapy with autologous bone marrow transplantation and full dose radiotherapy for grade IV astrocytoma. ⬇️

artículo científico publicado en 1988

High-dose chemotherapy and autologous bone marrow transplantation for relapsed and refractory Hodgkin's disease.

artículo científico publicado en 1992

Image-guided biopsy in women with breast cancer presenting with peritoneal carcinomatosis

artículo científico publicado en 2006

Implications of ejection fraction value for trastuzumab

artículo científico publicado en 2006

Improved Survival from Ovarian Cancer in Patients Treated in Phase III Trial Active Cancer Centres in the UK. ⬇️

artículo científico publicado en 2016

Lymphomas of the cervix and upper vagina: A report of five cases and a review of the literature ⬇️

artículo científico publicado el 1 de enero de 1992

Mucinous epithelial ovarian carcinoma. ⬇️

artículo científico publicado en 2016

Mucinous tumours of the ovary.

artículo científico publicado en 2011

Multiple myeloma treated with high dose intravenous melphalan

scientific article published on 01 May 1987

Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials

artículo científico publicado en 2018

Optimized sequence of drug administration and schedule leads to improved dose delivery for gemcitabine and paclitaxel in combination: a phase I trial in patients with recurrent ovarian cancer

artículo científico publicado en 2006

Ovarian cancer: advances in first-line treatment strategies with a particular focus on anti-angiogenic agents.

artículo científico

Paclitaxel (Taxol) in relapsed and refractory ovarian cancer: the UK and Eire experience. ⬇️

artículo científico publicado en 1995

Phase II study of docetaxel in combination with epirubicin and protracted venous infusion 5-fluorouracil (ETF) in patients with recurrent or metastatic breast cancer. A Yorkshire breast cancer research group study.

artículo científico publicado en 2004

Phase III randomized trial of doxorubicin and docetaxel versus doxorubicin and cyclophosphamide as primary medical therapy in women with breast cancer: an anglo-celtic cooperative oncology group study

artículo científico publicado en 2005

Positive and negative selection to reduce tumour contamination in peripheral blood stem cell harvests.

artículo científico publicado en 2000

Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial.

artículo científico publicado en 2015

Proteomic profiling identifies afamin as a potential biomarker for ovarian cancer.

artículo científico publicado en 2007

Randomized phase II placebo-controlled trial of maintenance therapy using the oral triple angiokinase inhibitor BIBF 1120 after chemotherapy for relapsed ovarian cancer.

artículo científico publicado en 2011

Role of front-line bevacizumab in advanced ovarian cancer: the OSCAR study

artículo científico publicado en 2019

Routine chest radiography following imaging-guided placement of tunneled central lines: a waste of time, money, and radiation.

artículo científico publicado en 2002

Serial MRI scans help in assessing early response to neoadjuvant chemotherapy and tailoring breast cancer treatment. ⬇️

artículo científico publicado en 2016

Subcutaneous administration of recombinant glycosylated interleukin 6 in patients with cancer: pharmacokinetics, pharmacodynamics and immunomodulatory effects.

artículo científico publicado en 2000

Targeted anti-vascular therapies for ovarian cancer: current evidence ⬇️

artículo científico publicado en 2013

The Cost-Effectiveness of Bevacizumab in Advanced Ovarian Cancer Using Evidence from the ICON7 Trial.

artículo científico publicado en 2016

The Cytotoxics Handbook.

artículo científico publicado en 1991

The calpain system is associated with survival of breast cancer patients with large but operable inflammatory and non-inflammatory tumours treated with neoadjuvant chemotherapy ⬇️

scientific article published on 15 June 2016

The prophylactic role of intravenous and long-term oral acyclovir after allogeneic bone marrow transplantation ⬇️

artículo científico publicado en 1989

The use of tumour markers CEA, CA-195 and CA-242 in evaluating the response to chemotherapy in patients with advanced colorectal cancer. ⬇️

artículo científico publicado en 1993

The value of computed tomographic (CT) scan surveillance in the detection and management of brain metastases in patients with small cell lung cancer. ⬇️

artículo científico publicado en 1990

Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial.

artículo científico publicado en 2007

Treatment of relapsed and refractory acute leukaemia with high-dose cytosine arabinoside and etoposide

artículo científico publicado en 1989

WWOX tumour suppressor gene polymorphisms and ovarian cancer pathology and prognosis.

artículo científico publicado en 2010

Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial

scientific article published on 29 November 2019

Women with peritoneal carcinomatosis of unknown origin: Efficacy of image-guided biopsy to determine site-specific diagnosis.

artículo científico publicado en 2007

c-erbB-2 oncogene as a prognostic marker in breast cancer ⬇️

artículo científico publicado el 1 de marzo de 1991

p-53 gene mutations as a predictive marker in a population of advanced breast cancer patients randomly treated with doxorubicin or docetaxel in the context of a phase III clinical trial

article

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda